Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Josep Nomdedeu"'
Autor:
Adrian Mosquera-Orgueira, Manuel Mateo Perez Encinas, Nicolas Diaz Varela, Yu-Hung Wang, Elvira Mora, Marina Diaz-Beya, Maria Julia Montoro, Helena Pomares Marin, Fernando Ramos Ortega, Mar Tormo, Andres Jerez, Josep Nomdedeu, Carlos de Migue Sanchez, Leonor Arenillas, Paula Carcel, Maria Teresa Cedena Romero, Blanca Xicoy Cirici, Eugenia Rivero Arango, Rafael Andrés Del Orbe Barreto, Luis Benlloch, Chien-Chin Lin, Hwei-Fang Tien, María Díez Campelo, Davide Crucitti, David Valcárcel
Publikováno v:
HemaSphere, Vol 7, p e69250c9 (2023)
Externí odkaz:
https://doaj.org/article/9a864d8e81c94889968de5acd5fa302c
Autor:
Miguel Argüello De Tomás, Nil Albiol, Alba Mora, Paola Jara, Esther Moga, Josep Nomdedeu, Marta Pratcorona Canela, Maria Laura Blanco, Jorge Sierra, Carol Moreno
Publikováno v:
HemaSphere, Vol 7, p e979440d (2023)
Externí odkaz:
https://doaj.org/article/8e62a828e8a04926b5e8891aeb39dd62
Autor:
Mireia Ramos‐Muntada, Juan L. Trincado, Joan Blanco, Clara Bueno, Virginia C. Rodríguez‐Cortez, Alex Bataller, Belén López‐Millán, Claire Schwab, Margarita Ortega, Pablo Velasco, Maria L. Blanco, Josep Nomdedeu, Manuel Ramírez‐Orellana, Alfredo Minguela, Jose L. Fuster, Esther Cuatrecasas, Mireia Camós, Paola Ballerini, Gabriele Escherich, Judith Boer, Monique DenBoer, Jesús M. Hernández‐Rivas, Maria J. Calasanz, Giovanni Cazzaniga, Christine J. Harrison, Pablo Menéndez, Oscar Molina
Publikováno v:
Molecular Oncology, Vol 16, Iss 16, Pp 2899-2919 (2022)
B‐cell acute lymphoblastic leukemia (B‐ALL) is the commonest childhood cancer. High hyperdiploidy (HHD) identifies the most frequent cytogenetic subgroup in childhood B‐ALL. Although hyperdiploidy represents an important prognostic factor in ch
Externí odkaz:
https://doaj.org/article/c4efc3858e8a4dd59893e2d44eb72c0d
Autor:
Muxin Gu, Maximillian Zwiebel, Swee Hoe Ong, Nick Boughton, Josep Nomdedeu, Faisal Basheer, Yasuhito Nannya, Pedro M. Quiros, Seishi Ogawa, Mario Cazzola, Roland Rad, Adam P. Butler, MS Vijayabaskar, George S. Vassiliou
Publikováno v:
Haematologica, Vol 105, Iss 6 (2020)
Externí odkaz:
https://doaj.org/article/a2c3b7eb743546c79a810d80e07d29a2
Autor:
Rafael Diaz de la Guardia, Belen Lopez-Millan, Jessie R. Lavoie, Clara Bueno, Julio Castaño, Maite Gómez-Casares, Susana Vives, Laura Palomo, Manel Juan, Julio Delgado, Maria L. Blanco, Josep Nomdedeu, Alberto Chaparro, Jose Luis Fuster, Eduardo Anguita, Michael Rosu-Myles, Pablo Menéndez
Publikováno v:
Stem Cell Reports, Vol 8, Iss 6, Pp 1573-1586 (2017)
Bone marrow mesenchymal stem/stromal cells (BM-MSCs) are key components of the hematopoietic niche thought to have a direct role in leukemia pathogenesis. BM-MSCs from patients with acute myeloid leukemia (AML) have been poorly characterized due to d
Externí odkaz:
https://doaj.org/article/8a601ea5525044378fac7231bc7d668a
Autor:
Adil S.A. Al Hinai, Marta Pratcorona, Tim Grob, François G. Kavelaars, Elena Bussaglia, Mathijs A. Sanders, Josep Nomdedeu, Peter J.M. Valk
Publikováno v:
HemaSphere, Vol 3, Iss 2 (2019)
Externí odkaz:
https://doaj.org/article/a40cb19e521949a8ba658710856ed39e
Autor:
Rafael Diaz de la Guardia, Belen Lopez-Millan, Heleia Roca-Ho, Clara Bueno, Francisco Gutiérrez-Agüera, Jose Luis Fuster, Eduardo Anguita, Samanta Romina Zanetti, Susana Vives, Josep Nomdedeu, Robert Sackstein, Jessie Lavoie, Elena Gónzalez-Rey, Mario Delgado, Michael Rosu-Myles, Pablo Menendez
Publikováno v:
Haematologica, Vol 104, Iss 2 (2019)
Externí odkaz:
https://doaj.org/article/5ca09c1c4466411dbf3ba0df1a71aada
Autor:
Esther Onecha, Maria Linares, Inmaculada Rapado, Yanira Ruiz-Heredia, Pilar Martinez-Sanchez, Teresa Cedena, Marta Pratcorona, Jaime Perez Oteyza, Pilar Herrera, Eva Barragan, Pau Montesinos, Jose Antonio Garcia Vela, Elena Magro, Eduardo Anguita, Angela Figuera, Rosalia Riaza, Pilar Martinez-Barranco, Beatriz Sanchez-Vega, Josep Nomdedeu, Miguel Gallardo, Joaquin Martinez-Lopez, Rosa Ayala
Publikováno v:
Haematologica, Vol 104, Iss 2 (2019)
A high proportion of patients with acute myeloid leukemia who achieve minimal residual disease negative status ultimately relapse because a fraction of pathological clones remains undetected by standard methods. We designed and validated a high-throu
Externí odkaz:
https://doaj.org/article/605b569d75a04455bc3a150eaf3934a4
Autor:
Jordi Ribera, Mireia Morgades, Isabel Granada, Anna Torrent, Lurdes Zamora, Teresa González, Juana Ciudad, Susana Barrena, Esperanza Such, Gayane Avetisyan, Maria José Calasanz, Eulàlia Genescà, Celia González-Gil, Francisco Fuster-Tormo, Santiago Mercadal, Clara Maluquer, Rosa Coll, José González-Campos, Mar Tormo, Irene García-Cadenas, Josep Nomdedeu, Cristina Gil, Marta Cervera, Lourdes Escoda, Pau Montesinos, Pere Barba, Jordi Esteve, Marina Díaz-Beyá, Pilar Martínez-Sánchez, Joaquín Martínez-López, Andrés Novo, M Paz Queipo, Arancha Bermúdez, Juan Bergua, M Teresa Olave, Beatriz De Rueda, M Teresa Artola, Jesús M Hernández-Rivas, Alberto Orfao, Josep M Ribera
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S207
Autor:
Oscar Gallego-Rubio, Cristian de Quintana-Schmidt, María Jesús Álvarez-Holzapfel, J. Molet-Teixidó, Andreas Leidinger, Silvia Bague-Rosell, Laura Salgado-López, Josep Nomdedeu-Guinot
Publikováno v:
Neurocirugía. 26:276-283
Resumen Objetivo La respuesta al tratamiento y el pronostico de los glioblastomas multiformes (GBM) puede ser distinta entre diferentes individuos. Este hecho esta haciendo que cada vez esten cobrando mas importancia los biomarcadores geneticos para